dilluns, 3 de desembre del 2018

‘Breakthrough’ eye-pressure sensor trial begins in Germany

(Image courtesy of Implandata)

Implandata Ophthalmic Products announced that the first patient in its international, multi-center, ARGOS-SC01 clinical study has been successfully implanted with its novel pressure sensor. This first-in-human clinical study is being conducted to validate the suprachoroidally placed Eyemate-SC, a sensor implant for continual monitoring of intraocular pressure (IOP).

While Implandata’s already CE-marked Eyemate-IO intraocular sensor implant is intended for use in glaucoma patients undergoing cataract surgery, the Eyemate-SC device allows implantation in glaucoma patients not indicated for cataract surgery yet, according to the Hanover, Germany company.

Get the full story on our sister site, Medical Design & Outsourcing.

The post ‘Breakthrough’ eye-pressure sensor trial begins in Germany appeared first on MassDevice.



from MassDevice https://ift.tt/2SrUEx8

Cap comentari:

Publica un comentari a l'entrada